銆€銆€鎹簡瑙o紝杩欑椋熷搧閰舵槸鐢包a href='//www.sqrdapp.com/news/tag_462.html' class='zdbq' title='闈炶浆鍩哄洜鐩稿叧椋熷搧璧勮' target='_blank'>闈炶浆鍩哄洜绫抽粦鏍规瘺
闇夎弻鏍狥RO鐢熶骇鐨勶紝鏃ㄥ湪鐢ㄤ簬涓夌椋熷搧鍒堕€犺繃绋嬶細鍔犲伐涔冲埗鍝佷互鐢熶骇濂堕叒銆侀鐢ㄥ嚌涔抽叾閰泲鐧藉拰鍙戦叺涔冲埗鍝併€侟/div>
銆€銆€缁忚繃璇勪及锛屼笓瀹跺皬缁勮涓猴紝鍦ㄩ鏈熺殑浣跨敤鏉′欢涓嬶紝涓嶈兘鎺掗櫎楗鏆撮湶寮曡捣杩囨晱鍙嶅簲鐨勯闄╋紝浣嗚繖绉嶅彲鑳芥€ц璁や负寰堜綆銆傛牴鎹墍鎻愪緵鐨勬暟鎹紝璇勪及灏忕粍寰楀嚭缁撹锛岃繖绉嶉鍝侀叾鍦ㄩ鏈熶娇鐢ㄦ潯浠朵笅涓嶄細寮曡捣瀹夊叏闂銆傞儴鍒嗗師鏂囨姤閬撳涓嬶細
銆€銆€The food enzyme mucorpepsin (EC 3.4.23.23) is produced with the non-genetically modified Rhizomucor miehei strain FRO by DSM Food Specialties B.V. The enzyme can be chemically modified to produce a thermolabile form. The food enzyme is free from viable cells of the production organism. It is intended to be used in three food manufacturing processes: processing of dairy products for the production of (1) cheese, (2) edible rennet casein, (3) fermented dairy products. Dietary exposure to the food enzyme–total organic solids (TOS) was estimated to be up to a
bout 0.072 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by means of a repeated dose 90-day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 2000 mg TOS/kg bw per day, the highest dose tested, which, when compared with the estimated dietary exposure, results in a margin of exposure of at least 27,778. A search for the similarity of the amino acid sequence of the food enzyme to known allergens was made and five matches were found. The Panel co
nsidered that a risk of allergic reactions upon dietary exposure to this food enzyme cannot be excluded, but is co
nsidered low, except for individuals sensitised to mustard proteins, for whom the risk will not exceed that of mustard consumption. ba
sed on the data provided, the Panel co
ncluded that this food enzyme does not give rise to safety co
ncerns under the intended co
nditions of use.
銆€銆€
鏈枃鐢遍鍝佷紮浼寸綉椋熷搧璧勮涓績缂栬緫锛屾湁浠讳綍鐤戦棶锛岃鑱旂郴news@foodmate.net銆侟/span>
鐩稿叧鏀跨瓥瑙h
